ExploreWatchlistsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash from financing

KYORIN Pharmaceutical Co., Ltd. (4569)

Market cap
¥106B
P/E ratio
19.6x
Kyorin Pharmaceutical manufactures and sells pharmaceutical products through an integrated system spanning from production to sales across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 20253,952-218.08%
Mar 31, 2024-3,347-0.48%
Mar 31, 2023-3,363-18.21%
Mar 31, 2022-4,112-16.39%
Mar 31, 2021-4,918-3.89%
Mar 31, 2020-5,117-81.27%
Mar 31, 2019-27,315+631.33%
Mar 31, 2018-3,735-34.71%
Mar 31, 2017-5,721+154.83%
Mar 31, 2016-2,245-57.10%
Mar 31, 2015-5,233

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat